Getein Biotech, Inc. Class A · SSE:603387

Getein Biotech, Inc. Class A financial statements

Getein Biotech, Inc. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.05B1.16B1.37B1.82B1.40B1.12B968.2M686.2M488.6M369.1M
Cost of revenue317.7M374.4M479.7M671.6M485.4M414.4M264.9M144.1M88.6M69.4M
Gross profit734.0M790.4M889.5M1.15B916.3M708.9M703.3M542.2M400.0M299.7M
Research and development157.4M181.2M218.0M223.2M163.4M119.1M104.7M80.6M54.0M39.3M
Selling, general and administrative79.6M95.7M106.8M103.9M90.6M75.9M63.2M54.9M37.7M68.6M
Operating income257.0M258.1M306.6M563.3M452.8M378.0M398.9M282.8M223.3M152.6M
Depreciation and amortization85.4M93.6M93.1M70.4M49.4M35.9M27.9M24.8M21.0M15.6M
EBITDA342.4M351.7M399.7M633.6M502.2M413.9M426.9M307.5M244.4M168.3M
Interest expense12.1M15.4M17.5M17.1M16.0M7.17M1.65M120.9K1.49M55.9K
Income before tax227.7M253.4M304.9M560.0M451.6M374.0M396.0M287.3M224.0M161.7M
Income tax23.6M20.9M56.0M39.6M43.7M46.0M36.6M30.2M23.3M
Net income220.7M223.6M279.8M498.9M399.0M304.7M339.7M249.6M194.0M138.4M
Earnings per share, basic0.440.440.550.980.780.600.660.490.450.36

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents313.9M351.6M484.3M646.2M968.9M801.5M659.5M145.4M301.0M26.3M
Short-term investments912.6M648.9M451.9M511.1M612.7M594.9M467.4M634.1M167.1M
Receivables359.5M407.8M478.6M496.9M446.0M472.0M247.8M79.3M33.4M31.9M
Inventory183.8M194.5M229.7M269.4M252.3M212.0M160.7M126.4M62.3M49.1M
Current assets2.30B1.86B2.15B2.40B2.37B2.12B1.57B1.28B1.05B279.2M
Property, plant and equipment556.5M452.2M369.6M296.8M231.4M174.9M122.5M
Goodwill12.0M309.7K26.1M26.1M26.1M26.1M309.7K309.7K309.7K
Total assets3.76B3.71B3.77B3.68B3.14B2.70B2.01B1.57B1.27B434.1M
Accounts payable190.2M145.9M129.1M121.4M121.1M118.3M67.0M26.8M11.0M9.66M
Current liabilities855.2M940.0M977.9M958.1M813.5M656.6M316.9M180.0M111.7M85.3M
Long-term debt3.00M27.8M20.0M
Total debt577.2M644.0M591.0M496.5M384.8M95.0M31.2M
Total liabilities896.6M986.4M1.03B1.01B863.9M695.9M326.0M187.2M118.9M91.1M
Shareholders' equity2.75B2.62B2.56B2.48B2.11B1.84B1.62B1.35B1.14B340.1M
Shares outstanding507.2M508.3M508.7M509.1M511.5M507.9M512.1M509.6M432.7M379.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations392.6M423.0M333.2M483.0M432.4M185.5M225.7M187.1M191.9M155.9M
Capital spending-150.6M-156.4M-258.1M-217.4M-179.6M-113.5M-124.8M-110.7M-61.4M-39.3M
Free cash flow242.0M266.6M75.1M265.5M252.8M71.9M100.9M76.4M130.6M116.6M
Cash from investing-348.1M-356.8M-760.4M-254.6M-238.7M261.8M-345.5M-519.3M-82.3M
Cash from financing-213.7M-145.9M-45.9M-28.9M200.0M25.9M-1.51M602.8M-59.2M
Dividends paid-103.2M-111.0M-219.4M-123.2M-93.2M-104.2M-76.3M-59.8M-68.2M-59.3M
Share buybacks-50.4M-541.8K-535.2K-654.3K
Change in cash-41.1M-132.9M-157.8M-304.2M147.8M140.7M514.2M-158.6M274.8M14.8M